Juliana Moreira Mendonça Gomes

Dr. Juliana Moreira Mendonça Gomes


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
JGJuliana Moreira Mendonça Gomes
Juliana Moreira Mendonça Gomes
ICIves Charlie-Silva
Ives Charlie-Silva
ASAnderson Kenedy Santos
Anderson Kenedy Santos
RRRodrigo Resende
Rodrigo Resende
ATAndréa Teixeira-Carvalho
Andréa Teixeira-Carvalho
JJJosé Dias Corrêa Junior
José Dias Corrêa Junior

Verified
Journal Article
Open access
PDF file
BPBarbara Nunes Padovani
Barbara Nunes Padovani
CFCamila Morales Fénero
Camila Morales Fénero
LPLais Cavalieri Paredes
Lais Cavalieri Paredes
MAMariana Abrantes do Amaral
Mariana Abrantes do Amaral
ODOmar Domínguez-Amorocho
Omar Domínguez-Amorocho
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
Cisplatin is an antineoplastic agent used to treat various tumors. In mammals, it can cause nephrotoxicity, tissue damage, and inflammation. The release of inflammatory mediators leads to the recruitment and infiltration of immune cells, particularly neutrophils, at the site of inflammation. Cisplatin is often used as an inducer of acute kidney injury (AKI) in experimental models, including zebrafish (Danio rerio), due to its accumulation in kidney cells. Current protocols in larval zebrafish focus on studying its effect as an AKI inducer but ignore other systematic outcomes. In this study, cisplatin was added directly to the embryonic medium to assess its toxicity and impact on systemic inflammation using locomotor activity analysis, qPCR, microscopy, and flow cytometry. Our data showed that larvae exposed to cisplatin at 7 days post-fertilization (dpf) displayed dose-dependent mortality and morphological changes, leading to a decrease in locomotion speed at 9 dpf. The expression of pro-inflammatory cytokines such as interleukin (il)-12, il6, and il8 increased after 48 h of cisplatin exposure. Furthermore, while a decrease in the number of neutrophils was observed in the glomerular region of the pronephros, there was an increase in neutrophils throughout the entire animal after 48 h of cisplatin exposure. We demonstrate that cisplatin can have systemic effects in zebrafish larvae, including morphological and locomotory defects, increased inflammatory cytokines, and migration of neutrophils from the hematopoietic niche to other parts of the body. Therefore, this protocol can be used to induce systemic inflammation in zebrafish larvae for studying new therapies or mechanisms of action involving neutrophils.

9 March 2021 in Fish and Shellfish Immunology Reports
Verified
Journal Article
Open access
JGJuliana Moreira Mendonça Gomes
Juliana Moreira Mendonça Gomes
TVThalita Marcolan Valverde
Thalita Marcolan Valverde
TMThaís Maria da Mata Martins
Thaís Maria da Mata Martins
ICIves Charlie-Silva
Ives Charlie-Silva
BPBarbara Nunes Padovani
Barbara Nunes Padovani
DGDawidson Assis Gomes
Dawidson Assis Gomes
• The dexamethasone reduced the number of peripheral circulating lymphocytes. • Dexamethasone provided a suitable environment for installation of breast tumor. • Prolonged use of dexamethasone allowed the success of xenografts in zebrafish. • Adult zebrafish as an excellent model to understand the biology of human cancer.

20 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
BFBianca Helena Ventura Fernandes
Bianca Helena Ventura Fernandes
NFNatália Martins Feitosa
Natália Martins Feitosa
ABAna Paula Barbosa
Ana Paula Barbosa
CBCamila Gasque Bomfim
Camila Gasque Bomfim
AGAnali Bernabe Garnique
Anali Bernabe Garnique
ICIves Charlie-Silva
Ives Charlie-Silva
Summary: Establishing new experimental animal models to assess the safety and immune response to the antigen used in the development of COVID-19 vaccine is an imperative issue. Based on the advantages of using zebrafish as a model in research, herein we suggest doing this to test the safety of the putative vaccine candidates and to study immune response against the virus. We produced a recombinant N-terminal fraction of the Spike SARS-CoV-2 protein and injected it into adult female zebrafish. The specimens generated humoral immunity and passed the antibodies to the eggs. However, they presented adverse reactions and inflammatory responses similar to severe cases of human COVID-19. The analysis of the structure and function of zebrafish and human Angiotensin-converting enzyme 2, the main human receptor for virus infection, presented remarkable sequence similarities. Moreover, bioinformatic analysis predicted protein-protein interaction of the Spike SARS-CoV-2 fragment and the Toll-like receptor pathway. It might help in the choice of future therapeutic pharmaceutical drugs to be studied. Based on the in vivo and in silico results presented here, we propose the zebrafish as a model for translational research into the safety of the vaccine and the immune response of the vertebrate organism to the SARS-CoV-2 virus.

1 November 2020 in Aquatic Toxicology
Verified
Journal Article
Closed access
JGJuliana Moreira Mendonça Gomes
Juliana Moreira Mendonça Gomes
ICIves Charlie-Silva
Ives Charlie-Silva
ASAnderson Kenedy Santos
Anderson Kenedy Santos
RRRodrigo Resende
Rodrigo Resende
ATAndréa Teixeira-Carvalho
Andréa Teixeira-Carvalho
JJJosé Dias Corrêa Junior
José Dias Corrêa Junior